Benzinga · Aug 12, 2026
Stephens & Co. Maintains Overweight on Amrize, Lowers Price Target to $54
Stephens & Co. analyst Trey Grooms maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $54.
NASDAQ · AMRZ
Basic Materials · Construction Materials
$44.63
Down-$0.99 (-2.17%)
Updated Aug 19, 2026, 4:43 AM
SID Score
5.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
AMRZ closed at $44.63 after 21 trading sessions, down 8.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $44.86 | $45.11 | $44.30 | $44.63 | 4.1M |
| Aug 17, 2026 | $46.57 | $46.815 | $45.655 | $45.73 | 4.18M |
| Aug 14, 2026 | $46.91 | $47.04 | $46.47 | $46.69 | 2.34M |
| Aug 13, 2026 | $46.69 | $47.08 | $46.21 | $46.75 | 2.75M |
| Aug 12, 2026 | $47.70 | $47.70 | $46.37 | $46.37 | 3.66M |
| Aug 11, 2026 | $46.77 | $47.74 | $46.43 | $47.60 | 4.81M |
| Aug 10, 2026 | $47.10 | $47.74 | $46.03 | $46.29 | 6.69M |
| Aug 7, 2026 | $47.50 | $48.78 | $46.305 | $46.64 | 9.53M |
| Aug 6, 2026 | $52.285 | $52.435 | $50.82 | $51.22 | 4.6M |
| Aug 5, 2026 | $52.13 | $53.01 | $51.86 | $52.88 | 2.9M |
| Aug 4, 2026 | $51.86 | $52.13 | $51.18 | $51.85 | 3.33M |
| Aug 3, 2026 | $49.50 | $51.19 | $49.50 | $51.08 | 2.8M |
| Jul 31, 2026 | $49.33 | $49.585 | $48.61 | $48.91 | 2.23M |
| Jul 30, 2026 | $51.04 | $51.04 | $49.37 | $49.60 | 3.82M |
| Jul 29, 2026 | $50.21 | $50.42 | $49.20 | $49.46 | 2.61M |
| Jul 28, 2026 | $50.21 | $51.00 | $49.905 | $50.37 | 1.94M |
| Jul 27, 2026 | $50.11 | $50.49 | $49.64 | $49.96 | 1.7M |
| Jul 24, 2026 | $48.56 | $49.38 | $48.19 | $49.25 | 2.52M |
| Jul 23, 2026 | $48.68 | $49.02 | $48.28 | $48.35 | 2.48M |
| Jul 22, 2026 | $49.06 | $50.41 | $49.06 | $49.56 | 2.82M |
| Jul 21, 2026 | $49.13 | $49.29 | $48.35 | $48.69 | 4.7M |
The latest Smart Investors Daily articles mentioning AMRZ.
AMRZ research
Company profile and research snapshot.
Amrize is a building solutions company focused exclusively on the North American market. Amrize earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. The company is organized into two reportable segments: building materials and building envelope. The building materials business consists of Amrize's cement, aggregates, ready-mix concrete, and asphalt operations. The building envelope segment offers advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 12, 2026 | Stephens & Co. | Overweight | — |
| Aug 11, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | RBC Capital | Underperform | — |
| Jul 21, 2026 | Oppenheimer | Outperform | — |
| Jul 8, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Benzinga · Aug 12, 2026
Stephens & Co. analyst Trey Grooms maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $54.
Benzinga · Aug 11, 2026
Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $66 to $58.
Fintel · Aug 11, 2026
Benzinga · Aug 10, 2026
RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning AMRZ.